Dyskeratosis congenita

Advances in Experimental Medicine and Biology

Volumn 685, Issue , 2010, Pages 215-219

  Gupta, Vineeta ^a   Kumar, Akash ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANDROGEN; ANTIBIOTIC AGENT; BLEOMYCIN; BUSULFAN; CYCLOSPORIN; DYSKERIN; ERYTHROPOIETIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY; MITOMYCIN C; OXYMETHOLONE; TELOMERASE; CELL CYCLE PROTEIN; DKC1 PROTEIN, HUMAN; NOLA3 PROTEIN, HUMAN; NUCLEAR PROTEIN; RNA; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; TELOMERASE RNA; TERT PROTEIN, HUMAN;

APLASTIC ANEMIA; ARTICLE; CELLULAR IMMUNITY; CLINICAL FEATURE; CYTOPENIA; DISEASE ASSOCIATION; DYSKERATOSIS CONGENITA; GAMMA IRRADIATION; GENETIC DISORDER; GENETICS; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; ADULT; B LYMPHOCYTE; BLOOD; BONE MARROW DISEASE; CHILD; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; PRESCHOOL CHILD; REVIEW; T LYMPHOCYTE; TELOMERE;

ADULT; ANDROGENS; B-LYMPHOCYTES; BONE MARROW DISEASES; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DYSKERATOSIS CONGENITA; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOCYTE COUNT; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; RNA; T-LYMPHOCYTES; TELOMERASE; TELOMERE;

EID: 77955875336     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6448-9_20     Document Type: Article

References (19)

1. Alter BP. Bone marrow failure syndrome in children. Pediatr Clin North Am 2002; 49:973-988. (Pubitemid 35247231)
2. Alter BP, Potter NU, Li FP. Classification and etiology of the aplastic anaemias. Clin Haematol 1978; 7:431-465.
3. Windass B, Vowels MR, O'Gorman Hughes D. Aplastic anemia in childhood: Prognosis and approach to therapy. Med J Aust 1987; 146:15-19. (Pubitemid 17047214)
4. Gupta V, Tripathi S, Singh TB et al. A study of bone marrow failure syndrome in children. Indian J Med Sci 2008; 62:13-18. (Pubitemid 351197549)
5. Tamary H, Alter BP. Current diagnosis of inherited bone marrow failure syndrome. Pediatr Hematol Oncol 2007; 24:87-99. (Pubitemid 46594593)
6. Alter BP. Diagnosis, genetics and management of inherited bone marrow failure syndrome. Hematology Am Soc Hematol Educ Program 2007;29-39.
7. Gupta V, Bhatia BD. Dyskeratosis congenita Indian Pediatr 2008; 45:936.
8. Ahmad, SI, Kirk, SH, eds. Molecular Mechanisms of Fanconi anemia. Austin/New York: Landes Bioscience/ Springer Science/Business Media Inc., 2006.
9. Mitchell JR, Wood E, Collins K. A telomere component is defective in the human disease: Dyskeratosis Congenita. Nature 1999; 402:551-555.
10. Vulliamy TJ, Marrone A, Dokal I et al. Association between aplastic anemia and mutations in telomerase RNA. Lancet 2002; 359:2168-2170. (Pubitemid 34694028)
11. Vulliamy TJ, Marrone A, Knight SW et al. Mutations in dyskeratosis congenita: Their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107:2680-2685.
12. Ortega JA, Swanson VL, Landig BH et al. Congenital Dyskeratosis: Zimmer-Engman-Cole syndrome with thymic dysplasia and aplastic anemia. Am J Dis Child 1972; 124:701-704.
13. Lee BW, Yap HK, Quah TC et al. T-cell immunodeficiency in Dyskeratosis Congenita. Arch Dis Child 1992; 67:524-526.
14. Knudson M, Kulharni S, Ballas ZK et al. Association of immune abnormalities with telomere shortening in autosomal dominant DC. Blood 2005; 105:682-688. (Pubitemid 40070753)
15. Cossu F, Vulliamy TJ, Marrone A. A novel DKCI mutation, severe combined immunodeficiency (T+B-NK-SCID) and BHT in and infant with Hoyeraal- Hreidarsson syndrome. Br J Haematol 2002; 119:765-768. (Pubitemid 35366220)
16. Gupta V, Bhatia BD. Immunological abnormalities in Dyskeratosis congenita. Indian Pediatr 2009; 46:448.
17. Giri N, Pitel N, Green D. Splenic peliosis and rupture in patients with Dyskeratosis congenita on androgens and G-CSF. Br J Haematol 2007; 138:815-817. (Pubitemid 47313211)
18. Connoli P, Basso S, Huanga GC. Intensive immunosuppression therapy for aplastic anemia associated with Dyskeratosis congenita: Report of a case. Int J Hematol 2006; 83:275-276.
19. de La Fuente J, Dokal I. Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant 2007; 11:584-594. (Pubitemid 47174390)